Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasms, Mesothelial × defactinib × Thoracic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Other solid neoplasm 1

Conditions

Mesothelioma, Malignant 4 Carcinoma, Non-Small-Cell Lung 4 Mesothelioma 2 Lung Neoplasms 2 Pancreatic Neoplasms 1 Neoplasms, Mesothelial 1 Adenoma 1 Adenocarcinoma of Lung 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02004028 2024-02-20

Window of Opportunity Study of VS-6063 (Defactinib) in Surgical Resectable Malignant Pleural Mesothelioma Participants

Verastem, Inc.

Phase 2 Terminated

35 enrolled 15 charts

Other solid neoplasmThoracic

Mesothelioma, Malignant, Adenoma, Mesothelioma, Neoplasms, Mesothelial

Data powered by HemOnc (CC BY 4.0) Colophon ⚡